—
According to the report, the global ophthalmic devices market garnered $32.53 billion in 2019, and is estimated to reach $44.86 billion by 2027, registering a CAGR of 4.0% from 2020 to 2027.Rise in adoption of digital devices in health care sector and incorporation of advanced technology in ophthalmic devicesdrive the growth of the global ophthalmic devices market. However, lack of sled professional and low awareness regarding eye-related diseases hinder the market growth. On the other hand, improvement in healthcare infrastructures creates new opportunities in the coming years.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/2046
Covid-19 scenario:
Disruptions in the supply chain have affected the manufacturing of surgical instrument and equipment, thereby impacting the ophthalmic devices market.
Moreover, people have become much conscious about necessary eye care measures and medical professionals have also started practicing preventive ophthalmology methods during the pandemic.
The report offers a detailed segmentation of the global ophthalmic devicesmarket based onproduct function, and region.
Based on product function, the vision care segment contributed to the largest share in 2019, accounting for nearly half of the total share, and is estimated to maintain its dominant position during the forecast period. However, thediagnostic devices segment is expected to register the highest CAGR of 4.7% from 2020 to 2027.
Based on region, North Americacontributed to the highest share, accounting for nearly two-fifths of the total market share in 2019, and will maintain its dominance throughout the forecast period. However, Asia-Pacific is expected to grow at the highest CAGR of 4.5% from 2020 to 2027.
The vision care segment to maintain its lead status-
Based on product function, the vision care segment accounted for nearly half of the global ophthalmic devices market in 2019, and is expected to maintain its lead status in terms of revenue throughout the forecast period. This is due to rise in trend of contact lenses and increase in number of patient with vision corrections. However, the diagnostic devices segment is estimated to portray the highest CAGR of 4.7% from 2020 to 2027. The changing consumer preference from traditional and manually operated refractors to auto-refractors drives the growth of the segment.
Leading market players
Abbott Laboratories
Novartis AG
Carl Zeiss Meditec AG
Essilor International S.A.
HAAG-Streit Holding AG
Johnson & Johnson
Nidek Co., Ltd.
Topcon Corporation
Valeant Pharmaceuticals International, Inc.
Ziemer Ophthalmic Systems AG.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2046
North America is anticipated to dominate the market by 2027-
Based on region, North America accounted for the highest share based on revenue, holding for nearly two-fifths of the global ophthalmic devices market in 2019, and is projected to maintain its dominant position throughout the forecast period. This is due to rise in number of blindness and low vision in the U.S. Moreover, Asia-Pacific region is estimated to generate the fastest CAGR of 4.5% from 2020 to 2027. This is attributed to the presence of high population base, increase in disposable income, and improvement in patient awareness about advanced ophthalmic devices in this region.
Contact Info:
Name: David Correa
Email: Send Email
Organization: Allied Market Research
Website: https://www.alliedmarketresearch.com/
Release ID: 89031869
Google
RSS